Real-World Outcomes of Perioperative Chemoimmunotherapy Completion in Resectable NSCLC

Zhoujunyi Tian's research dataset compares outcomes for patients with resectable non-small cell lung cancer who completed versus did not complete a full perioperative chemoimmunotherapy regimen. The dataset includes 164 patients (37 completed, 127 non-completed) and analyzes recurrence-free survival, overall survival, and adverse events. It was last updated on 2026-05-28 and is shared under a CC-BY-4.0 license.

Use Cases

• Compare recurrence-free survival between treatment adherence groups based on the Kaplan-Meier analysis described.
• Assess predictors of cancer recurrence based on variables like pathological nodal status mentioned in the results.
• Analyze the incidence of adverse events associated with completing the full treatment protocol.
• Conduct subgroup analyses to identify patient populations (e.g., age <65, ECOG score 0) that may benefit from treatment completion.

Strengths

• Includes data for 164 patients from a real-world clinical setting.
• Uses Inverse Probability of Treatment Weighting to adjust for baseline characteristics, as stated in the methods.
• Reports specific statistical results, including hazard ratios and p-values for survival comparisons.

Limitations

• Row count and column-level documentation are unknown, which limits suitability assessment.
• The dataset is very small at 15.6 KB, indicating limited scope.
• Data freshness should be verified as the last update is in the future (2026-05-28).

Provenance

Source

Zhoujunyi Tian via figshare

Collection Method

Clinical study of patients with resectable non-small cell lung cancer who received neoadjuvant chemoimmunotherapy followed by surgery.

Freshness

Last updated 2026-05-28 04:45:43; freshness should be verified.